Showing results (2041-2050 of 2,356) with videos related to

Sort By:
Pageof 236
Thrombosis and Haemostasis|April 4, 2018
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS RegistryAlberto Garay, Albert Ariza-Solé, Francesc Formiga, et al.
Thrombosis Research|August 2, 2018
Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-studyKajetan Grodecki, Zenon Huczek, Piotr Scisło, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 5, 2015
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's diseaseChristina M Lill, Aina Rengmark, Lasse Pihlstrøm, et al.
American Heart Journal|April 15, 2018
Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)Thomas O Bergmeijer, Jean-Luc Reny, Ruth E Pakyz, et al.
Clinical Pharmacology and Therapeutics|May 31, 2020
Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics ConsortiumShefali Setia Verma, Thomas O Bergmeijer, Li Gong, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS RegistriesMattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.
International Journal of Cardiology|February 7, 2018
Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS scoreSergio Raposeiras-Roubín, Jonas Faxén, Andrés Íñiguez-Romo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 11, 2019
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patientsJoshua P Lewis, Joshua D Backman, Jean-Luc Reny, et al.
European Heart Journal. Acute Cardiovascular Care|May 2, 2019
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary interventionSergio Raposeiras-Roubín, Emad Abu-Assi, Berenice Caneiro Queija, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
Pageof 236